Oral Oncology Reports最新文献_第10页

Rare case of glandular odontogenic cyst in the posterior mandibular ramus: A case report 下颌后隆突腺源性牙源性囊肿的罕见病例：病例报告

Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100586

Nasem Jamal Yousef, Issa Saad, Marwan Al-Raeei, Chadi Azmeh, Maya Saad, Zeina Darwich, Maya Jokhadar, Ammar Nasser Agha, Waad Omran, Thayer Marouf

{"title":"Rare case of glandular odontogenic cyst in the posterior mandibular ramus: A case report","authors":"Nasem Jamal Yousef, Issa Saad, Marwan Al-Raeei, Chadi Azmeh, Maya Saad, Zeina Darwich, Maya Jokhadar, Ammar Nasser Agha, Waad Omran, Thayer Marouf","doi":"10.1016/j.oor.2024.100586","DOIUrl":"10.1016/j.oor.2024.100586","url":null,"abstract":"<div><p>The glandular odontogenic cyst is a rare developmental cyst with odontogenic origins that shares similarities with other odontogenic lesions. While generally considered benign, GOCs can exhibit aggressive behavior and may transform into more aggressive lesions like ameloblastoma or mucoepidermoid carcinoma. Therefore, it is crucial to closely monitor and follow up after treatment. With less than 200 reported cases in the literature, GOCs are important due to their propensity for recurrence and potential confusion with other lesions. Oral and maxillofacial radiologists play a key role in diagnosing GOC, given its complex histopathology. In this particular case, a 14-year-old male presented with a well-defined radiolucent lesion in his posterior mandibular ramus, making it the third reported case of GOC in Syria. The discovery of the lesion was incidental, as it was found during a routine panoramic view. The radiolucent lesion extended from the distal border and apex of the lower right first premolar into the ramus, indicating the need for thorough diagnostic evaluation and proper management of the condition. This case report emphasizes the importance of recognizing and addressing such lesions early on to prevent any potential complications. As GOCs can be locally aggressive and have a tendency to recur, timely diagnosis and appropriate treatment are crucial in ensuring the best possible outcome for the patient. Further studies and research are needed to better understand the characteristics and behavior of GOCs in the mandibular ramus region.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004321/pdfft?md5=b4ee69158513ddae47d08f44daa9e24c&pid=1-s2.0-S2772906024004321-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141715687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comment on “Salivary exosomes as potential biomarkers in cancer” 关于 "作为癌症潜在生物标记物的唾液外泌体 "的评论

Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100577

Muthupandian Saravanan

引用次数: 0

Letter to editor: Comment on “multi-omics approach reveals promising salivary protein markers for head and neck squamous cell carcinoma prognosis" 致编辑的信关于 "多组学方法揭示了头颈部鳞状细胞癌预后的唾液蛋白标记 "的评论

Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100595

Gokul Sudhakaran

引用次数: 0

Letter to the editor, “Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – Implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy.” 致编辑的信，"头颈部鳞状细胞癌（HNSCC）的深度依赖性PD-L1取样--对PD-1/PD-L1检查点抑制剂免疫疗法的影响"。

Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100579

Geetha Shanmugam

引用次数: 0

Unlocking the potential of antimicrobial peptides: Beta-defensins and the future of cancer diagnostics 发掘抗菌肽的潜力：β-防御素与癌症诊断的未来

Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100584

Saranya Velmurugan, Gowtham Kumar Subbaraj

引用次数: 0

Letter to the editor, “Prevalence of oral side effects associated with chemo and radiotherapy in head and neck cancer treatment: A cross-sectional study in Egypt” 致编辑的信，"头颈部癌症化疗和放疗相关口腔副作用的发生率：埃及横断面研究"

Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100578

Gnanaprakash Jeyaraj

引用次数: 0

End of life and palliative care decisions in advanced head neck cancer 晚期头颈部癌症患者的生命终结和姑息治疗决策

Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100569

Shrikant B. Mali

{"title":"End of life and palliative care decisions in advanced head neck cancer","authors":"Shrikant B. Mali","doi":"10.1016/j.oor.2024.100569","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100569","url":null,"abstract":"<div><p>The complexity of care for patients with advanced head and neck cancer is a significant issue, and current healthcare systems must focus on appropriate referral criteria, increased integration and coordination of care, and robust evaluation of specific care components. Linkage between research and service design delivery across teams, disciplines, and care settings is also important. Palliative care needs of patients with advanced head and neck cancer pose unique complexities due to the impact the illness has on eating, speaking, appearance, and breathing. Specialty palliative care consultation by trained experts helps primary teams facilitate goals of care discussions, symptom management, and medical resource navigation for the terminally ill patient. Early initiation of palliative care results in less invasive and more cost-effective patient-centered care. There is little literature on care practices in this population, and hospital-based care may increase towards the end of life to address potentially reversible conditions or uncertain prognosis. Early advanced care planning and end-of-life care options should be supported alongside continuation of therapy lines.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004151/pdfft?md5=a10e435122de333102e63e386f9366c9&pid=1-s2.0-S2772906024004151-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comment on “Unlocking the therapeutic potential of microalgal astaxanthin a super antioxidant in oral cancer and associated ailments” 关于 "挖掘微藻虾青素这种超级抗氧化剂对口腔癌及相关疾病的治疗潜力 "的评论

Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100571

Antonyraj Matharasi Perianaika Anahas, Ganapathy Dhanraj

引用次数: 0

Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent? 二甲双胍的再利用：作为一种新辅助治疗药物，它能否彻底改变口腔癌治疗？

Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100575

Deepavalli Arumuganainar, Saravanan Sekaran

引用次数: 0

Comment on, “How reliable is the assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? A multi-institutional study on 366 patients from the ARYFIX collaborative group” 评论："评估喉癌患者声带-声门单元真实活动度的可靠性如何？ARYFIX合作小组对366名患者进行的一项多机构研究"

Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100568

Gokul Sudhakaran

引用次数: 0